Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ·Healthcare·Biotechnology
$4.42
+2.43%
Mkt Cap $2.09B
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (23 analysts)
$4.00
Range $2.00 – $5.00
Implied Upside
-9.4%
Consensus $4.00 vs current $4.42
NASDAQ·Healthcare·Biotechnology
$4.42
+2.43%
Mkt Cap $2.09B
Buy
3
Hold
1
Sell
0
Price Target (23 analysts)
$4.00
Range $2.00 – $5.00
-9.4%
Consensus $4.00 vs current $4.42